Nrf2 Activation and Antioxidant Properties of Chromone-Containing MTDLs for Alzheimer’s Disease Treatment
Molecules · 2025
DOI: 10.3390/molecules30092048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Alexey Simakov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Université Marie et Louis Pasteur, INSERM UMR1322 LINC, F-25000 Besançon, France. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Alzheimer Disease, Antioxidants, Chromones. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder affecting millions worldwide and imposing a significant social and economic burden. Despite extensive research, there is still no effective cure for this disease. AD is multifactorial and involves multiple etiopathogenic mechanisms, one of which is oxidative stress. Consequently, the Nrf2/ARE pathway, which regulates the expression of cellular defense genes, including those for antioxidant enzymes, is considered to be a prospective therapeutic target for AD. Meanwhile, multitarget-directed ligands (MTDLs) are a promising approach for developing effective AD medications. In this regard, we evaluated the antioxidant potential of eight chromone-containing MTDLs in vitro, including Nrf2 transcriptional activation potencies, Nrf2/ARE downstream genes activation, and antioxidant effects in vitro. All tested compounds effectively activated the Nrf2/ARE pathway. Notably, compounds 4b, 4c, 4f, and 4h demonstrated the highest Nrf2 activation potencies, while compounds 4b, 4c, 4d, and 4g significantly induced the expression of Nrf2-target antioxidant genes, specifically NQO1 and HO1. Additionally, compound 4d exhibited a significant antioxidant effect in vitro. These findings encourage further investigation of the studied compounds, with particular emphasis on compound 4d as the most promising candidate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Marie et Louis Pasteur, INSERM UMR1322 LINC, F-25000 Besançon, France.
- Université Marie et Louis Pasteur, EFS, INSERM UMR1098 RIGHT, F-25000 Besançon, France.
ORCID-Profile: Alexey Simakov, Lhassane Ismaili, Hélène Martin
Zitieren
APA
Simakov, A., Chhor, S., Ismaili, L., & Martin, H. (2025). Nrf2 Activation and Antioxidant Properties of Chromone-Containing MTDLs for Alzheimer’s Disease Treatment. Molecules. https://doi.org/10.3390/molecules30092048
Vancouver
Simakov A, Chhor S, Ismaili L, Martin H. Nrf2 Activation and Antioxidant Properties of Chromone-Containing MTDLs for Alzheimer’s Disease Treatment. Molecules. 2025. doi:10.3390/molecules30092048
BibTeX
@article{Simakov2025,
author = {Simakov, Alexey and Chhor, Stecy and Ismaili, Lhassane and Martin, Hélène},
title = {Nrf2 Activation and Antioxidant Properties of Chromone-Containing MTDLs for Alzheimer’s Disease Treatment},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30092048}
}
EUVIMED